The FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test is a specialized diagnostic tool used to identify mutations in the FBN1 gene, which are associated with Weill-Marchesani Syndrome (WMS) type 2. This rare genetic disorder is characterized by short stature, brachydactyly (short fingers), reduced joint flexibility, and eye abnormalities, among other symptoms. The dominant inheritance pattern of this type means that a mutation in just one of the two copies of the FBN1 gene can cause the disorder.
The test is crucial for individuals with a family history of WMS or those showing symptoms, as an early and accurate diagnosis can lead to better management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to look for specific mutations in the FBN1 gene that are known to cause the syndrome.
The cost of the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test is 4400 AED. While the price may seem high, the test provides invaluable information for affected individuals and their families, including insights into treatment options, management strategies, and genetic counseling for future family planning.
The WRN Gene Werner Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the WRN gene that are responsible for Werner Syndrome. Werner Syndrome is a rare, autosomal recessive disorder characterized by premature aging and an increased risk of cancer and other age-related diseases. The test is crucial for individuals with a family history of the syndrome or those exhibiting symptoms, as early detection can significantly aid in managing the condition and improving the quality of life. The genetic test involves analyzing the individual's DNA to pinpoint any alterations in the WRN gene that might indicate the presence of Werner Syndrome. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and confidentiality. The cost of the WRN Gene Werner Syndrome Genetic Test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the invaluable insights it provides into managing the syndrome effectively.
The KMT2A Gene Wiedemann-Steiner Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the KMT2A gene, which are associated with Wiedemann-Steiner Syndrome (WSS). WSS is a rare genetic disorder characterized by distinctive facial features, developmental delay, short stature, and hypertrichosis. The test is crucial for the accurate diagnosis of the syndrome, enabling tailored treatment and management plans for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to detect any abnormalities in the KMT2A gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to ensure accurate results. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of WSS, facilitating informed decisions regarding care and support.
The Chr. 7q11.23 Gene Williams-Beuren Syndrome Genetic Test is a specialized diagnostic tool used to identify the genetic markers associated with Williams-Beuren Syndrome (WBS), a complex developmental disorder. This test specifically targets the chromosome 7q11.23 region, where deletions are known to cause the syndrome. WBS is characterized by cardiovascular disease, developmental delays, and unique facial features, among other symptoms.
DNA Labs UAE offers this crucial genetic testing service for individuals suspected of having WBS or for families seeking genetic counseling. The test is performed using advanced genetic sequencing technologies to accurately detect the presence of deletions in the 7q11.23 region. A positive result can help in the early diagnosis and management of the syndrome, allowing for tailored medical and educational interventions.
The cost of the Chr. 7q11.23 Gene Williams-Beuren Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the test procedure, analysis, and comprehensive reporting. The results from this test provide valuable insights into the genetic underpinnings of WBS, aiding in the understanding and support of affected individuals.
The MSX1 gene plays a crucial role in dental development, and mutations in this gene can lead to Witkop syndrome, also known as tooth-and-nail syndrome. This condition is characterized by nail dysplasia and missing teeth (tooth agenesis). To diagnose this genetic condition, DNA Labs UAE offers a specialized genetic test targeting the MSX1 gene.
The test is designed to identify mutations in the MSX1 gene that are associated with Witkop syndrome. It involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for genetic abnormalities linked to the syndrome.
The cost of the MSX1 Gene Witkop Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive testing not only aids in the diagnosis of Witkop syndrome but also helps in understanding the risk of passing the condition to the next generation, thereby providing essential information for family planning and management of the syndrome.
The ERCC4 Gene XFE Progeroid Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ERCC4 gene, which are associated with XFE Progeroid Syndrome. This rare genetic disorder is characterized by features resembling accelerated aging, including growth delays, skin abnormalities, and a higher susceptibility to cancer. The test, costing 4400 AED, involves analyzing the patient's DNA to detect any genetic alterations in the ERCC4 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families. Through this advanced genetic testing, DNA Labs UAE offers a vital resource for early detection and understanding of XFE Progeroid Syndrome, facilitating personalized treatment plans and improving patient outcomes.
The ZIC5 gene plays a crucial role in early brain development and is associated with various neurodevelopmental disorders. Mutations in the ZIC5 gene can lead to a spectrum of brain-related conditions, which may include developmental delays, intellectual disabilities, and structural brain anomalies. Recognizing the importance of early diagnosis and intervention, genetic testing for ZIC5-related disorders has become an invaluable tool in the medical field.
DNA Labs UAE offers a comprehensive genetic test specifically designed to analyze the ZIC5 gene for mutations that could be linked to brain disorders. This test is pivotal for individuals who have clinical symptoms suggestive of a ZIC5-related condition or have a family history of such disorders. Early detection through this genetic test can facilitate timely management and support for affected individuals, enhancing their quality of life and providing crucial information for family planning.
The test is conducted with a high degree of accuracy and confidentiality, ensuring patients receive reliable results. The cost of the ZIC5 genetic test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise involved in the testing process. Upon completion, a detailed report is provided, which can be used to guide further medical care, therapeutic interventions, and genetic counseling.
In summary, the ZIC5 genetic test offered by DNA Labs UAE is a critical resource for diagnosing ZIC5-related brain disorders, aiding in the understanding and management of these complex conditions.
The Breast Cancer BRCA1 and BRCA2 Gene Test is a crucial diagnostic tool available at DNA Labs UAE, aimed at identifying mutations in the BRCA1 and BRCA2 genes. These genes, when functioning normally, help suppress tumors and repair DNA, playing a significant role in preventing breast and ovarian cancer. However, mutations in these genes can significantly increase an individual's risk of developing these cancers.
This test is particularly recommended for individuals with a family history of breast, ovarian, or related cancers, as it can provide vital information for making informed decisions about preventive measures and treatment options. The process involves a simple blood or saliva sample from which DNA is extracted and analyzed for specific mutations in the BRCA1 and BRCA2 genes.
At DNA Labs UAE, the Breast Cancer BRCA1 BRCA2 Gene Test is priced at 2000 AED. This cost includes the comprehensive analysis and a detailed report, which can be a valuable resource for both patients and their healthcare providers in managing and mitigating cancer risk effectively. The test is conducted with strict confidentiality and precision, ensuring reliable results for those seeking clarity about their genetic predisposition to breast and ovarian cancers.
The DNMT3A gene plays a crucial role in the development of acute myeloid leukemia (AML), a type of cancer that starts in the cells that are supposed to mature into different types of blood cells. Mutations in the DNMT3A gene are among the most common genetic alterations found in AML patients, and these mutations are somatic, meaning they are acquired rather than inherited. These alterations can affect the gene's normal function in DNA methylation, a process that is critical for controlling gene expression. As a result, the faulty DNMT3A gene can contribute to the uncontrolled growth of abnormal white blood cells characteristic of leukemia.
To aid in the diagnosis and management of AML, DNA Labs UAE offers a specialized genetic test that focuses on identifying somatic mutations in the DNMT3A gene. This test is a valuable tool for clinicians in tailoring treatment plans for patients, as the presence of DNMT3A mutations can influence prognosis and response to certain therapies. By detecting these mutations early, healthcare providers can make more informed decisions regarding intervention strategies, potentially improving patient outcomes.
The test is priced at 3000 AED and is conducted at DNA Labs UAE, a facility equipped with state-of-the-art technology for genetic testing. This investment in the DNMT3A related genetic test could be pivotal for patients diagnosed with AML, offering them a personalized approach to treatment that could significantly impact their recovery journey.
The PTCH1 gene plays a crucial role in the development and progression of Basal Cell Nevus Syndrome (BCNS), also known as Gorlin Syndrome. This condition is characterized by the appearance of multiple basal cell carcinomas, jaw cysts, skeletal abnormalities, and other systemic manifestations. The genetic test for the PTCH1 gene aims to identify mutations that are responsible for BCNS, thereby enabling early diagnosis and intervention.
At DNA Labs UAE, individuals can undergo the PTCH1 gene test, which is meticulously designed to detect alterations in the gene that are linked to Basal Cell Nevus Syndrome. This test is crucial for individuals with a family history of BCNS or those displaying symptoms related to the syndrome. Early detection through genetic testing can significantly influence the management and treatment strategies, potentially reducing the risk of complications associated with the syndrome.
The cost of the PTCH1 gene test at DNA Labs UAE is 4400 AED. This investment includes a comprehensive analysis of the PTCH1 gene to identify any mutations. The test is conducted under strict quality control measures, ensuring accurate and reliable results. By opting for this genetic test, individuals gain valuable insights into their genetic makeup, empowering them with the knowledge to make informed decisions regarding their health and the management of BCNS.
